Loading clinical trials...
Loading clinical trials...
Phase 2a, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of ALTB-268 in Subjects With Moderately to Severely Active Ulcerative Colitis Refractory to Biologic Therapy
Conditions
Interventions
ALTB-268
Locations
24
United States
San Diego Gastroenterology
San Diego, California, United States
Rocky Mountain Gastroenterology
Littleton, Colorado, United States
Gastro Health Research
Miami, Florida, United States
Digestive and Liver Center of Florida, LLC
Orlando, Florida, United States
Alliance Clinical Research of Tampa, LLC.
Tampa, Florida, United States
Gastro Health Partners Southern Indiana
New Albany, Indiana, United States
Start Date
December 4, 2023
Primary Completion Date
April 1, 2026
Completion Date
March 1, 2027
Last Updated
January 2, 2026
NCT07550673
NCT06372613
NCT07374471
NCT06071312
NCT05739864
NCT07271069
Lead Sponsor
AltruBio Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions